Press Center
2021-06-30
[KR] NGeneBio registered a patent for the analysis algorithm of cancer-related genetic variants
NGeneBio registered a Korean patent for the analysis algorithm of cancer-related genetic variants. The patent…
2021-05-28
[KR] Molecular epidemiological study of metastatic prostate cancer with Asan Medical Center
NGeneBio is conducting the study of molecular mechanisms of metastatic prostate cancer-related gene mutations with…
2019-02-25
NGeneBio Raises $11M
NEW YORK (GenomeWeb) – Korean diagnostics firm NGeneBio said this week that it recently closed…
2017-07-12
After Securing CE-IVD for Debut Hereditary Cancer Dx, Korea’s NGeneBio Readies NGS Tests for Launch
NEW YORK (GenomeWeb) – Fresh from achieving a CE-IVD mark for its flagship next-generation sequencing…
